Category:Unknown-importance pharmacology articles
 | Administrators: Please do not delete this category as empty! This category may be empty occasionally or even most of the time. |
| Top | High | Mid | Low | NA | ??? |
| 120 | 879 | 3,127 | 6,566 | 2,449 | 3,486 |
Pages in category "Unknown-importance pharmacology articles"
The following 200 pages are in this category, out of approximately 3,486 total. This list may not reflect recent changes.
(previous page) (next page)O
- Talk:Obetrol
- Talk:Obexelimab
- Talk:Obinutuzumab
- Talk:Oblimersen
- Talk:Ocaratuzumab
- Talk:Ocedurenone
- Talk:Ocinaplon
- Talk:Octodrine
- Talk:Odalasvir
- Talk:Odanacatib
- Talk:Odapipam
- Talk:Odilorhabdin
- Talk:ODMA (drug)
- Talk:Odulimomab
- Talk:Peter Oehme
- Talk:Off-target activity
- Talk:Officina Profumo-Farmaceutica di Santa Maria Novella
- Talk:Ofranergene obadenovec
- Talk:Akira Ogata
- Talk:Olamkicept
- Talk:Morẹ́nikẹ́ Ọláòṣebìkan
- Talk:Olcegepant
- Talk:Oleclumab
- Talk:Oleoyl-estrone
- Talk:Oleoylethanolamide
- Talk:Oligodynamic effect
- Talk:Olmutinib
- Talk:Olodaterol
- Talk:Olokizumab
- Talk:Olorofim
- Talk:Olpasiran
- Talk:Omacetaxine mepesuccinate
- Talk:Omapatrilat
- Talk:Omarigliptin
- Talk:Shamil Omarov
- Talk:Ombitasvir
- Talk:Omigapil
- Talk:Omoconazole
- Talk:On Immunity
- Talk:Onartuzumab
- Talk:Oncology Drug Advisory Committee
- Talk:Oneirogen
- Talk:Online pharmacy laws in India
- Talk:ONX-0801
- Talk:OPC-64005
- Talk:Opelconazole
- Talk:Ophthalmic drug administration
- Talk:Opioid modulator
- Talk:Opiorphin
- Talk:Opium in Iran
- Talk:Opodeldoc
- Talk:Oportuzumab monatox
- Talk:Oral administration
- Talk:Oral glucose gel
- Talk:Ordesekimab
- Talk:Oregovomab
- Talk:Org 28312
- Talk:Ormetoprim
- Talk:Ornidazole
- Talk:Ortho-DOT
- Talk:Ortho-McNeil Pharmaceutical
- Talk:Ortho-Methoxyphenylpiperazine
- Talk:Orthocaine
- Talk:Orticumab
- Talk:Orvepitant
- Talk:Osanetant
- Talk:Osavampator
- Talk:OSI-7904
- Talk:Osmotic diuretic
- Talk:Osoresnontrine
- Talk:Otamixaban
- Talk:Otelixizumab
- Talk:Otlertuzumab
- Talk:Otsuka Pharmaceutical
- Talk:OU Citizen Science Soil Collection Program
- Talk:Oxaceprol
- Talk:Oxametacin
- Talk:Oxatomide
- Talk:Oxelumab
- Talk:Oxfendazole
- Talk:Oxiconazole
- Talk:Oxidized cellulose
- Talk:Oxilofrine
- Talk:Oxilorphan
- Talk:Oxiperomide
- Talk:Oxiracetam
- Talk:Oxitropium bromide
- Talk:Oxolinic acid
- Talk:Oxomemazine
- Talk:Oxotremorine
- Talk:Oxpheneridine
- Talk:Oxycinchophen
- Talk:Oxycodegol
- Talk:Oxymorphazone
- Talk:Oxypertine
- Talk:Oxyphenbutazone
- Talk:Oxyphenisatine
- Talk:Oxytocin/ergometrine
- Talk:Ozagrel
- Talk:Ozanezumab
- Talk:Ozoralizumab
P
- Talk:P-Methoxyfentanyl
- Talk:Pacritinib
- Talk:Padimate A
- Talk:Padimate O
- Talk:Pagibaximab
- Talk:Pagoclone
- Talk:Palivizumab
- Talk:Pamidronic acid
- Talk:Pamrevlumab
- Talk:Pan-assay interference compounds
- Talk:Panadiplon
- Talk:Panadol night
- Talk:Surendra Nath Pandeya
- Talk:Panipenem
- Talk:Panipenem/betamipron
- Talk:Panobacumab
- Talk:Vassilios Papadopoulos
- Talk:Papaveretum
- Talk:Papaverine
- Talk:Para-Iodoamphetamine
- Talk:Para-Methoxyphenylpiperazine
- Talk:Paracetamol/metoclopramide
- Talk:Parachute (drugs)
- Talk:Paramethasone
- Talk:Paraoxon
- Talk:Parecoxib
- Talk:Paricalcitol
- Talk:Parnaparin sodium
- Talk:Paromomycin
- Talk:PARP inhibitor
- Talk:Parsatuzumab
- Talk:Partial agonist
- Talk:Pascolizumab
- Talk:Pateclizumab
- Talk:Patient education
- Talk:Patritumab
- Talk:Martin Paul (professor)
- Talk:PDE3 inhibitor
- Talk:PDE4 inhibitor
- Talk:PDM-35
- Talk:Pegdinetanib
- Talk:Peginesatide
- Talk:Peginterferon alfa-2b
- Talk:Pegipanermin
- Talk:Pegloticase
- Talk:Pegol
- Talk:Pegozafermin
- Talk:Pegsunercept
- Talk:Pelacarsen
- Talk:Pemtumomab
- Talk:Pemvidutide
- Talk:Penamecillin
- Talk:Penbutolol
- Talk:Penciclovir
- Talk:Dale Pendell
- Talk:Pentamorphone
- Talk:Pentavalent antimonial
- Talk:Pentazocine
- Talk:Penthienate
- Talk:Pentorex
- Talk:Pentostatin
- Talk:Pentoxyverine
- Talk:Pentyl nitrite
- Talk:PEPA (drug)
- Talk:PEPAP
- Talk:Perakizumab
- Talk:Perazine
- Talk:Perflubron
- Talk:Perimycin
- Talk:Jacques Personne
- Talk:Peruvoside
- Talk:Perzinfotel
- Talk:Pethidine intermediate A
- Talk:Pethidinic acid
- Talk:Petrelintide
- Talk:Petrichloral
- Talk:Pexacerfont
- Talk:Pexelizumab
- Talk:PF-3845
- Talk:PF-04455242
- Talk:PGG-glucan
- Talk:Phanquinone
- Talk:Pharmac
- Talk:Pharmaceutical Accountability Foundation
- Talk:Pharmaceutical code
- Talk:Pharmaceutical fraud
- Talk:Pharmaceutical Inspection Convention and Pharmaceutical Inspection Co-operation Scheme
- Talk:Pharmaceutical lobby
- Talk:Pharmaceutical manufacturing
- Talk:Pharmaceutical Services Negotiating Committee
- Talk:Pharmaceutical Society of Northern Ireland
- Talk:Pharmaceutics
- Talk:Pharmacie du Cerf
- Talk:Pharmaciens Sans Frontières
- Talk:List of pharmacists
- Talk:Pharmacists for Future
- Talk:Pharmacoepidemiology
- Talk:Pharmacokinetics simulation
- Talk:Pharmacological Calvinism